Latest news
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 10:01:15 GMTMIRA Reports Positive 7-Day Dog Study Results for SKNY-1 - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:22:16 GMTCompass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights - Via RitzauVia Ritzau · Wed, 05 Aug 2026 10:30:00 GMT